Bullish Case: ZETA ($29.45) rides a 17-quarter beat-and-raise streak, raised FY26 guidance ($1.818B rev/$405M EBITDA), Athena/Palantir momentum, and a Citi $35 target. Call flow leads puts by 25%, bullish risk exceeds bearish by 11%, and Helium's density peaks near $29.5-30.5 with contango suggesting post-event IV decay supports grinding higher toward $32-35.

Bearish Case: After a 52-week high and +43.5% year, valuation leaves no execution margin. Helium's term structure shows a violent Nov 7 IV anomaly (15% vs 123% band wings) signaling event-driven uncertainty, and Helium density shows fat downside tails below $25 that the market underweights. Mean-reverting price action after -2.5% month and 1st-percentile option liquidity invite gap risk on any Q3 miss or privacy/regulatory headline.

Potential Outcomes:

1. 35% Consolidation $28-32 through Q4 earnings cycle; Helium density peaks at $29-30.5. Falsified by weekly close <$27.
2. 25% Upside to $32-35 on Athena adoption and continued analyst raises; call-heavy flow supports it.
3. 22% Pullback to $25-28 on post-52-week-high profit-taking; mean-reverting regime favors this.
4. 12% Q3 earnings (early Nov) gap move beyond $35 or below $25; Nov expiry IV ~70% prices ~$6 move.
5. 3% Shock <$23 from regulatory/privacy headline; thin liquidity amplifies.

September 26, 2026